+ All Categories
Home > Documents > Continuing Education Invites You To…€¦ · Mercer University College of Pharmacy. Faculty...

Continuing Education Invites You To…€¦ · Mercer University College of Pharmacy. Faculty...

Date post: 14-Jun-2020
Category:
Upload: others
View: 0 times
Download: 0 times
Share this document with a friend
1
For more CE opportunities, please visit: www.pharmacytimes.org CHAPTER MEETING Pharmacy Times Continuing Education Invites You To… The Rapidly Evolving Treatment Landscape for Hepatocellular Carcinoma February 17, 2020 6:00PM Metropolitan Ballroom & Clubroom • 5418 Wayzata Blvd • Golden Valley, MN 55416 FACULTY Amber Draper, PharmD, BCOP Clinical Pharmacy Specialist Gastrointestinal Oncology Emory Winship Cancer Institute Adjunct Professor Mercer University College of Pharmacy Faculty disclosures will be provided prior to the presentation. EDUCATIONAL OBJECTIVES Identify characteristics, including risk factors, that would suggest a patient should be referred for potential evaluation for HCC Describe the current drug classes that are used in the treatment of patients with advanced HCC and their placement in guidelines Explain what therapies are currently being studied for the treatment of advanced HCC and their potential places in therapy Develop monitoring plans for patients undergoing treatment for advanced HCC, including management of dosing recommendations, drug interactions, and adverse effects Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-19-226-L01-P. The activity is available for CE credit through June 23, 2020. Type of Activity: Application This activity is supported by educational grants from Bayer HealthCare Pharmaceuticals Inc.; Eisai Inc.; Exelixis, Inc.; and Merck Sharp & Dohme Corp. FACULTY Amber Draper, PharmD, BCOP, completed her pharmacy school training at Mercer University College of Pharmacy. She then went on to complete both a PGY-1 general and PGY-2 oncology/ hematology residency at UAB Hospital. She is currently the Clinical Pharmacy Specialist in the gastrointestinal (GI) malignancy clinic of the Emory Winship Cancer Institute in Atlanta where her role involves collaboration with the healthcare team to ensure medications prescribed for patients are appropriate and effective, bringing about positive health outcomes. She also maintains an active role in research at Winship with a focus on GI malignancies. Amber is an adjunct professor at Mercer’s College of Pharmacy, serving as preceptor to P4 students.
Transcript
Page 1: Continuing Education Invites You To…€¦ · Mercer University College of Pharmacy. Faculty disclosures will be provided prior to the presentation. EDUCATIONAL OBJECTIVES • Identify

For more CE opportunities, please visit:www.pharmacytimes.org

CHAPTERM E E T I N G

Pharmacy Times Continuing Education™

Invites You To…The Rapidly Evolving Treatment Landscape for Hepatocellular CarcinomaFebruary 17, 2020 • 6:00pm Metropolitan Ballroom & Clubroom • 5418 Wayzata Blvd • Golden Valley, MN 55416

FACULTY

Amber Draper, PharmD, BCOPClinical Pharmacy SpecialistGastrointestinal OncologyEmory Winship Cancer InstituteAdjunct ProfessorMercer University College of Pharmacy

Faculty disclosures will be provided prior to the presentation.

EDUCATIONAL OBJECTIVES

• Identify characteristics, including risk factors, that would suggest apatient should be referred for potential evaluation for HCC

• Describe the current drug classes that are used in the treatment ofpatients with advanced HCC and their placement in guidelines

• Explain what therapies are currently being studied for the treatment ofadvanced HCC and their potential places in therapy

• Develop monitoring plans for patients undergoing treatment foradvanced HCC, including management of dosing recommendations, druginteractions, and adverse effects

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-19-226-L01-P. The activity is available for CE credit through June 23, 2020.

Type of Activity: Application

This activity is supported by educational grants from Bayer HealthCare Pharmaceuticals Inc.; Eisai Inc.; Exelixis, Inc.; and Merck Sharp & Dohme Corp.

FACULTYAmber Draper, PharmD, BCOP, completed her pharmacy school training at Mercer University College of Pharmacy. She then went on to complete both a PGY-1 general and PGY-2 oncology/hematology residency at UAB Hospital. She is currently the Clinical Pharmacy Specialist in the

gastrointestinal (GI) malignancy clinic of the Emory Winship Cancer Institute in Atlanta where her role involves collaboration with the healthcare team to ensure medications prescribed for patients are appropriate and effective, bringing about positive health outcomes. She also maintains an active role in research at Winship with a focus on GI malignancies. Amber is an adjunct professor at Mercer’s College of Pharmacy, serving as preceptor to P4 students.

Recommended